Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...
Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback